©2008 The WJG Press and Baishideng.
World J Gastroenterol. Aug 21, 2008; 14(31): 4849-4860
Published online Aug 21, 2008. doi: 10.3748/wjg.14.4849
Published online Aug 21, 2008. doi: 10.3748/wjg.14.4849
Table 3 Selected traditional and novel factors associated with the increased risk of CMV disease after liver transplantation
| Traditional factors | Recently identified factors |
| CMV D+/R- > CMV R+ | Toll-like receptor gene polymorphism |
| Allograft rejection | Mannose binding lectin deficiency |
| High viral replication | Chemokine and cytokine defects (IL-10, MCP-1, CCR5) |
| Mycophenolate mofetil | Deficiency in CMV-specific CD4+ T cells |
| Muromonab-CD3 | Deficiency in CMV-specific CD8+ T cells |
| Anti-thymocyte globulin | Expression of immune evasion genes |
| Alemtuzumab | Programmed cell death 1 expression |
| HHV-6 | |
| HHV-7 | |
| Renal insufficiency | |
| Others1 |
- Citation: Razonable RR. Cytomegalovirus infection after liver transplantation: Current concepts and challenges. World J Gastroenterol 2008; 14(31): 4849-4860
- URL: https://www.wjgnet.com/1007-9327/full/v14/i31/4849.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.4849